These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 968899)

  • 1. A "natural" anti-HLA-A2 antibody reacting with homozygous cells.
    Lepage V; Degos L; Dausset J
    Tissue Antigens; 1976 Aug; 8(2):139-42. PubMed ID: 968899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A "spontaneous" cold-reactive IgM antibody with anti HLA-B8 specificity in a patient with multiple sclerosis.
    Lenhard V; Diehm H; Römer W; Rauterberg EW; Kownatzki E; Roelcke D
    Immunobiology; 1982 Feb; 160(5):382-91. PubMed ID: 6175560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-D typing with homozygous lymphoblastoid cell lines.
    Netzel B; Bornkamm G; Lenhard V; Scholz S; Grosse-Wilde H
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):85-9. PubMed ID: 868208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue antigens and cytotoxic antibodies in polycythaemia rubra vera.
    Nagy G; Stenszky V; Murvay K
    Haematologia (Budap); 1975; 9(3-4):279-82. PubMed ID: 1230410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of HLA antigens on blood platelets and lymphocytes by means of monoclonal antibodies in an ELISA technique.
    Lansdorp PM; Oosterhof F; Astaldi GC; Zeijlemaker WP
    Tissue Antigens; 1982 Jan; 19(1):11-9. PubMed ID: 6176045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of an HL-A antiserum by iso-electric focusing.
    Reisner EG; Reisner HM; Chung KS; Folds JD; Amos DB
    J Immunol; 1975 Oct; 115(4):1084-6. PubMed ID: 240883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
    Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II
    Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of monospecific anti-HL-A antisera.
    Mittal KK
    Vox Sang; 1975; 29(6):418-32. PubMed ID: 1210226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HLA-B12 on platelets, on lymphocytes and in serum: a quantitative study.
    Liebert M; Aster RH
    Tissue Antigens; 1977 Apr; 9(4):199-208. PubMed ID: 69335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoelectric focusing of an anti-HL-A2 antiserum cross-reacting with W28.
    Reisner EG; Su Chung KS; Folds JD; Amos DB
    Tissue Antigens; 1976 Mar; 7(3):151-7. PubMed ID: 936200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional correlation between antibody-dependent and spontaneous cytotoxic activity of human lymphocytes and possibility of an HLA-related control.
    Trinchieri G; Santoli D; Zmijewski CM; Koprowski H
    Transplant Proc; 1977 Mar; 9(1):881-4. PubMed ID: 867507
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral blood B cells producing donor-specific HLA antibodies in vitro.
    Han M; Rogers JA; Lavingia B; Stastny P
    Hum Immunol; 2009 Jan; 70(1):29-34. PubMed ID: 19026703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of common determinants of HLA antigens A2 and B17 by absorption using human HLA serum].
    Májský A; Korínková P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):768-72. PubMed ID: 6198261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.
    Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL
    J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The demonstration of HL-A antigens on thrombocytes under various conditions].
    Bube FW; Seegers D; Siebel E; Heumann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):240-7. PubMed ID: 61918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
    Bodmer H; Ogg G; Gotch F; McMichael A
    Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
    Takahashi T; Irie RF; Nishinaka Y; Hoon DS
    Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to crossreactive HLA antigens. Evaluation by cytotoxicity, flow cytometry, and inhibition of monoclonal antibody binding.
    Scornik JC; LeFor WM
    Transplantation; 1987 Feb; 43(2):235-40. PubMed ID: 3544381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antileukocyte and antithrombocyte antibodies in correlation with the incidence of cytotoxic anti-HL-A antibodies in hematologic diseases of various etiology].
    Dinić B; Susaković N
    Bilt Hematol Transfuz; 1976; 4(3):11-6. PubMed ID: 1087555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.